Education
About Us
Working with TipRanks
Follow Us
Stoke Therapeutics Inc (STOK)
NASDAQ:STOK
STOK Analyst Ratings
Strong Buy
9 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
STOK Stock 12 Month Forecast
Average Price Target
$45.25
▲(36.34% Upside)
| Highest Price Target$60.00 | Average Price Target$45.25 | Lowest Price Target$35.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
H.C. Wainwright
$50
Buy
50.65%
Upside
Reiterated
03/20/26
Canaccord Genuity
$36→$60
Buy
80.78%
Upside
Reiterated
03/20/26
Guggenheim
$60
Buy
80.78%
Upside
Reiterated
03/18/26
Wedbush
$38
Buy
14.49%
Upside
Reiterated
03/18/26
BTIG
$39
Buy
17.51%
Upside
Reiterated
03/18/26
TD Cowen
―
Buy
―
Reiterated
03/17/26
Needham
$40
Buy
20.52%
Upside
Assigned
03/17/26
Wolfe Research
$40
Buy
20.52%
Upside
Initiated
02/23/26
Chardan Capital
$35
Buy
5.45%
Upside
Reiterated
01/05/26
Jefferies
$30
Buy
-9.61%
Downside
Reiterated
11/24/25
J.P. Morgan
$15→$25
Hold
-24.68%
Downside
Reiterated
11/03/25
Leerink Partners
$18→$30
Buy
-9.61%
Downside
Reiterated
10/07/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
$50
Buy
50.65%
Upside
Reiterated
03/20/26
Canaccord Genuity
$36→$60
Buy
80.78%
Upside
Reiterated
03/20/26
Guggenheim
$60
Buy
80.78%
Upside
Reiterated
03/18/26
Wedbush
$38
Buy
14.49%
Upside
Reiterated
03/18/26
BTIG
$39
Buy
17.51%
Upside
Reiterated
03/18/26
TD Cowen
―
Buy
―
Reiterated
03/17/26
Needham
$40
Buy
20.52%
Upside
Assigned
03/17/26
Wolfe Research
$40
Buy
20.52%
Upside
Initiated
02/23/26
Chardan Capital
$35
Buy
5.45%
Upside
Reiterated
01/05/26
Jefferies
$30
Buy
-9.61%
Downside
Reiterated
11/24/25
J.P. Morgan
$15→$25
Hold
-24.68%
Downside
Reiterated
11/03/25
Leerink Partners
$18→$30
Buy
-9.61%
Downside
Reiterated
10/07/25
Best Analysts Covering Stoke Therapeutics
3 Months
xxx
Success Rate
8/11 ratings generated profit
Average Return
+21.87%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 72.73% of your transactions generating a profit, with an average return of +21.87% per trade.
1 Year
Success Rate
11/13 ratings generated profit
Average Return
+114.12%
Copying Sumant Kulkarni's trades and holding each position for 1 Year would result in 84.62% of your transactions generating a profit, with an average return of +114.12% per trade.
2 Years
xxx
Success Rate
13/13 ratings generated profit
Average Return
+187.70%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +187.70% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
STOK Analyst Recommendation Trends
Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
3
4
6
4
6
Buy
9
9
11
9
13
Hold
1
1
1
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
13
14
18
13
19
Each month's total comprises the sum of three months' worth of ratings.
STOK Financial Forecast
STOK Stock Forecast FAQ
What is STOK’s average 12-month price target, according to analysts?
Based on analyst ratings, Stoke Therapeutics Inc’s 12-month average price target is 45.25.
What is STOK’s upside potential, based on the analysts’ average price target?
Stoke Therapeutics Inc has 36.34% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is STOK a Buy, Sell or Hold?
Stoke Therapeutics Inc has a consensus rating of Strong Buy which is based on 9 buy ratings, 0 hold ratings and 0 sell ratings.
What is Stoke Therapeutics Inc’s price target?
The average price target for Stoke Therapeutics Inc is 45.25. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $60.00 ,the lowest forecast is $35.00. The average price target represents 36.34% Increase from the current price of $33.19.
The highest analyst price target is $60.00 ,the lowest forecast is $35.00. The average price target represents 36.34% Increase from the current price of $33.19.
What do analysts say about Stoke Therapeutics Inc?
Stoke Therapeutics Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 9 Wall Streets Analysts.
How can I buy shares of STOK?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.